{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-282025-03-28233221100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-282025-03-28233221100
Download SVG
Download PNG
Download CSV

bnp paribas and charles schwab increase stakes in healthequity stock

BNP Paribas Financial Markets increased its stake in HealthEquity by 165.7% in Q3, now holding 20,437 shares valued at $1.67 million. Charles Schwab Investment Management also raised its position by 2.4% in Q4, owning over 1 million shares worth $104.28 million. Institutional investors control 99.55% of the stock, which has a current average rating of "Buy" and a consensus target price of $112.23.

acv auctions insider sales and institutional investments update

Insiders sold 455,911 shares of ACV Auctions stock valued at $7.48 million in the last three months, with insiders owning 8.50% of the company. Institutional investors hold 88.55% of the stock, with Wellington Management increasing its stake by 61.3% to 1.7 million shares. JPMorgan Chase & Co. cut its price target for ACV Auctions from $24 to $20, suggesting a potential upside of 37.19%. The stock currently has a "Moderate Buy" rating, with an average target price of $23.14, while trading at $14.58.

IAC stock receives mixed ratings from analysts amid market fluctuations

IAC (NASDAQ:IAC) has received an "overweight" rating from JPMorgan Chase & Co., with a price target of $60, indicating a potential upside of 23.61%. Analysts have mixed views, with a "Moderate Buy" average rating and a price target of $64.31, while institutional investors hold 88.90% of the stock. The company's market cap stands at $3.76 billion, with shares trading at $48.54.

sportradar group receives price target upgrades from multiple analysts

XTX Topco Ltd has increased its holdings in Sportradar Group to 25,591 shares, valued at $444,000, after acquiring 1,414 shares last quarter. Sportradar, which provides sports data services globally, has received multiple price target upgrades from analysts, with an average target of $23.22 and a current rating of "Moderate Buy." The stock recently traded at $22.55, reflecting a market cap of $25.06 billion and a 52-week range between $9.17 and $23.00.

ubs maintains buy rating on madrigal pharmaceuticals with target price of 441

UBS has reaffirmed its Buy rating on Madrigal Pharmaceuticals, setting a price target of $441, reflecting confidence in the company's potential in treating metabolic-associated steatohepatitis (MASH). Following strong fourth-quarter results, with revenues of $180 million and a gross margin of 96.54%, analysts remain optimistic about Madrigal's future, particularly with promising data from the Phase 3 MAESTRO-NAFLD-1 trial. The company holds a robust financial position, with cash and marketable securities totaling $931.3 million, and anticipates a potential European launch of its drug Rezdiffra in 2025, pending regulatory approval.

essex property trust sees mixed analyst ratings and significant institutional investment

Ensign Peak Advisors Inc increased its stake in Essex Property Trust, owning 27,704 shares valued at $7.54 million. The company, a fully integrated REIT, manages 252 apartment communities on the West Coast. Analysts have mixed ratings, with a consensus "Hold" and a price target averaging $305.53.

institutional investors increase stakes in epr properties amid mixed analyst ratings

Natixis has increased its holdings in EPR Properties to 72,764 shares, valued at $3,089,000, after acquiring 47,534 shares last quarter. Price T Rowe Associates also boosted its stake by 48.3%, now owning 61,346 shares worth $2,605,000. Institutional investors hold 74.66% of the company's stock, which has a consensus "Hold" rating and a price target of $48.28.
13:45 14.11.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.